Opioidergic modulation of ventilatory response to sustained hypoxia in obese Zucker rats

Obesity Research

Volumn 9, Issue 7, 2001, Pages 407-413

  Lee, Shin Da ^a   Magalang, Ulysses J ^b   Krasney, John A ^b   Farkas, Gaspar A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Hypoxia; Naloxone; Obesity; Opioids; Respiration

Indexed keywords

ANIMALIA;

17 METHYLNALOXONE; CARBON DIOXIDE; DRUG DERIVATIVE; NALOXONE; NARCOTIC ANTAGONIST; OPIATE PEPTIDE; OXYGEN; QUATERNARY AMMONIUM DERIVATIVE;

ANIMAL; ANOXIA; ARTICLE; BLOOD; DRUG EFFECT; KINETICS; LUNG GAS EXCHANGE; LUNG VENTILATION; MALE; MORBID OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; RAT; ZUCKER RAT;

ANIMALS; ANOXIA; CARBON DIOXIDE; KINETICS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; OBESITY, MORBID; OPIOID PEPTIDES; OXYGEN; PULMONARY GAS EXCHANGE; PULMONARY VENTILATION; QUATERNARY AMMONIUM COMPOUNDS; RANDOM ALLOCATION; RATS; RATS, ZUCKER;

EID: 0035403087     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2001.53     Document Type: Article

References (28)

1. Morgan EJ, Zwillich CW. The obesity-hypoventilation syndrome. West J Med. 1978;129:387-93.
2. Orlowski JP, Herrell DW, Moodie DS. Narcotic antagonist therapy of the obesity hypoventilation syndrome. Crit Care Med. 1982;10:604-7.
3. Zwillich CW, Sutton FD, Pierson DJ, Greagh EM, Weil JV. Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome. Am J Med. 1975;59:343-8.
4. Dempsey JA, Reddan W, Rankin J, Balke B. Alveolar-arterial gas exchange during muscular work in obesity. J Appl Physiol. 1966;21:1807-14.
5. Farkas GA, Schlenker EH. Pulmonary ventilation and mechanics in morbidly obese Zucker rats. Am J Respir Crit Care Med. 1994;150:356-62.
6. Lee SD, Nakano H, Gosselin LE, Krasney JA, Schlenker EH, Farkas GA. Endogenous opioids modulate ventilation and peak oxygen consumption in obese Zucker rats. Am J Respir Crit Care Med. 2000;162:1009-15.
7. Lee SD, Nakano H, Farkas GA. GABAergic modulation of ventilation in obese Zucker rats. J Appl Physiol. 2001;90: 1707-13.
8. Lee SD, Nakano H, Farkas GA. NMDA receptor mediated modulation of hypoxic ventilatory response in obese Zucker rats. Int J Obes Relat Metab Disord. 2001. (in press).
9. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. Anatomy of CNS opioid receptors. Trends Neurosci. 1988;11:308-14.
10. Santiago TV, Edelman NH. Opioids and breathing. J Appl Physiol. 1985;59:1675-85.
11. Freedman A, Scardella AT, Edelman NH, Santiago TV. Hypoxia does not increase CSF or plasma beta-endorphin activity. J Appl Physiol. 1988;64:966-71.
12. Kagawa S, Stafford MJ, Waggener TB, Severinghaus JW. No effect of naloxone on hypoxia-induced ventilatory depression in adults. J Appl Physiol. 1982;52:1030-4.
13. Schlenker EH, Farkas GA. Endogenous opioids modulate ventilation in the obese Zucker rat. Respir Physiol. 1995;99: 97-103.
14. Cozzolino D, Sessa G, Salvatore T, Sasso FC, Giugliano D, Torella R. The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people. J Clin Endocrinol Metab. 1996;81:713-8.
15. Giugliano D, Lefebvre PJ. A role for beta-endorphin in the pathogenesis of human obesity? Horm Metab Res. 1999;23: 251-6.
16. Margules DL, Moisset B, Lewis MJ, Shibuya H, Pert CB. Beta-endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa). Science. 1978;202:988-91.
17. Gozal D, Gozal E, Simakajornboon N. Signaling pathways of the acute hypoxic ventilatory response in the nucleus tractus solitarius. Respir Physiol. 2000;121:209-21.
18. Neubauer JA, Posner MA, Santiago TV, Edelman NH. Naloxone reduces ventilatory depression of brain hypoxia. J Appl Physiol. 1987;63:699-706.
19. Drorbaugh JE, Fenn WO. A barometric method for measuring ventilation in newborn infants. Pediatrics. 1955;16:81-6.
20. Jacky JP. Barometric measurement of tidal volume: effects of pattern and nasal temperature. J Appl Physiol. 1980;49:319-25.
21. Refinetti R. Computation of the body mass for metabolic studies of lean and obese rats. Metabolism. 1989;38:763-6.
22. Pert CB, Snyder SH. Opiate receptor binding: enhancement by opiate administration in vivo. Biochem Pharmacol. 1976; 25:847-53.
23. Yeadon M, Kitchen I. Opioids and respiration. Prog Neurobiol. 1989;33:1-16.
24. Pokorski M, Lahiri S. Effects of naloxone on carotid body chemoreception and ventilation in the cat. J Appl Physiol. 1981;51:1533-8.
25. Deviche P. Affinity of naloxone and its quaternary analogue for avian central delta and μ-opioid receptors. Brain Res. 1997;757:276-9.
26. Gestreau C, Le Guen S, Besson JM. Is there tonic activity in the endogenous opioid systems? A c-Fos study in the rat central nervous system after intravenous injection of naloxone or naloxone-methiodide. J Comp Neurol. 2000:427:285-301.
27. Negri L, Lattanzi R, Tabacco F, Melchiorri P. Respiratory and cardiovascular effects of the μ-opioid receptor agonist [Lys7]dermorphin in awake rats. Br J Pharmacol. 1998; 124: 345-55.
28. Atkinson RL, Suratt PM, Wilhoit SC. Naloxone improves sleep apnea in obese humans. Int J Obes Relat Metab Disord. 1985;9:233-9.